Ceftazidime-avibactam resistance in KPC-producing Klebsiella pneumoniae accompanied hypermucoviscosity acquisition
Abstract Background Antimicrobial resistance and bacterial hypermucoviscosity, associated with escalating production of capsules, constitute major challenges for the clinical management of Klebsiella pneumoniae (K. pneumoniae) infections. This study investigates the association and underlying mechan...
Saved in:
| Main Authors: | Yingyi Guo, Jiong Wang, Likang Yao, Yijing Wang, Yan Zhang, Chuyue Zhuo, Xu Yang, Feifeng Li, Jiahui Li, Baomo Liu, Nanhao He, Jiakang Chen, Shunian Xiao, Zhiwei Lin, Chao Zhuo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-10-01
|
| Series: | BMC Microbiology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12866-024-03508-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evolution of ceftazidime-avibactam resistance driven by variation in blaKPC-2 to blaKPC-190 during treatment of ST11-K64 hypervirulent Klebsiella pneumoniae
by: Zeshi Liu, et al.
Published: (2025-06-01) -
In vitro mimicry of in vivo KPC mutations by ceftazidime-avibactam: phenotypes, mechanisms, genetic structure and kinetics of enzymatic hydrolysis
by: Siquan Shen, et al.
Published: (2024-12-01) -
In vivo evolution to hypermucoviscosity and ceftazidime/avibactam resistance in a liver abscess caused by Klebsiella pneumoniae sequence type 512
by: Valerio Capitani, et al.
Published: (2024-09-01) -
Whole-genome sequencing characterisation of a new KPC-245 variant-carrying Klebsiella pneumoniae strain isolated from a transplanted patient and resistant to ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam
by: Claudia Vaiana, et al.
Published: (2025-05-01) -
Molecular mechanisms responsible KPC-135-mediated resistance to ceftazidime-avibactam in ST11-K47 hypervirulent Klebsiella pneumoniae
by: Qingyu Shi, et al.
Published: (2024-12-01)